Literature DB >> 11821095

High serum luteinizing hormone and testosterone concentrations do not predict pregnancy outcome in women with recurrent miscarriage.

Luciano G Nardo1, Raj Rai, May Backos, Safaa El-Gaddal, Lesley Regan.   

Abstract

OBJECTIVE: To investigate the relationship between Day 8 serum luteinizing hormone (LH) and testosterone (T) concentrations, and body mass index (BMI) with pregnancy outcome in women with recurrent miscarriage.
DESIGN: Prospective observational study.
SETTING: National recurrent miscarriage clinic. PATIENT(S): Three hundred forty-four women (median age 32 years; range 18-44) with a history of recurrent first trimester miscarriage (median 4; 3-14; <12 weeks gestation) who conceived spontaneously and who received no pharmacological treatment during pregnancy were studied. All women were antiphospholipid antibody negative and had a normal peripheral karyotype as did their partners. INTERVENTION(S): Outcome of untreated pregnancies. MAIN OUTCOME MEASURE(S): Day 8 serum LH and T concentrations and BMI were correlated with pregnancy outcome. RESULT(S): One hundred and ninety-two (55.8%) women had a live birth and 152 (44.2%) women miscarried. Polycystic ovarian morphology was diagnosed in 174 women (50.6%). There was no significant relationship between follicular phase LH concentrations and pregnancy outcome. Pregnancy outcome was similar in women with normal and high serum T concentrations. BMI value was not significantly different between women who had a live birth and those who miscarried. CONCLUSION(S): The analysis of this large cohort of women with recurrent miscarriage demonstrates that prepregnancy Day 8 serum LH and T concentrations, and BMI do not have a statistically significant relationship with pregnancy outcome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11821095     DOI: 10.1016/s0015-0282(01)02995-8

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  5 in total

1.  Comparison of embryological and clinical outcome in GnRH antagonist vs. GnRH agonist protocols for in vitro fertilization in PCOS non-obese patients. A prospective randomized study.

Authors:  Rafal Kurzawa; Przemyslaw Ciepiela; Tomasz Baczkowski; Krzysztof Safranow; Pawel Brelik
Journal:  J Assist Reprod Genet       Date:  2008-09-19       Impact factor: 3.412

2.  Effects of propylene glycol or elevated luteinizing hormone during follicle development on ovulation, fertilization, and early embryo development.

Authors:  Katherine S Hackbart; Robb W Bender; Paulo D Carvalho; Lais M Vieira; Ana R Dresch; Jerry N Guenther; Hidir Gencoglu; Anibal B Nascimento; Randy D Shaver; Milo C Wiltbank
Journal:  Biol Reprod       Date:  2017-10-01       Impact factor: 4.285

3.  DHEA-mediated inhibition of the pentose phosphate pathway alters oocyte lipid metabolism in mice.

Authors:  Patricia T Jimenez; Antonina I Frolova; Maggie M Chi; Natalia M Grindler; Alexandra R Willcockson; Kasey A Reynolds; Quihong Zhao; Kelle H Moley
Journal:  Endocrinology       Date:  2013-09-13       Impact factor: 4.736

4.  ESHRE guideline: recurrent pregnancy loss.

Authors:  Ruth Bender Atik; Ole Bjarne Christiansen; Janine Elson; Astrid Marie Kolte; Sheena Lewis; Saskia Middeldorp; Willianne Nelen; Braulio Peramo; Siobhan Quenby; Nathalie Vermeulen; Mariëtte Goddijn
Journal:  Hum Reprod Open       Date:  2018-04-06

5.  Men, trans/masculine, and non-binary people's experiences of pregnancy loss: an international qualitative study.

Authors:  Damien W Riggs; Ruth Pearce; Carla A Pfeffer; Sally Hines; Francis Ray White; Elisabetta Ruspini
Journal:  BMC Pregnancy Childbirth       Date:  2020-08-24       Impact factor: 3.007

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.